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In insulinoma cell lines proliferation and insulin gene transcription are stimulated by growth hormone and prolactin, which convey their signals
through the transcription factors Stat5a and 5b (referred to as Stat5). However, the contribution of Stat5 to the physiology of β-cells in vivo could
not be assessed directly since Stat5-null mice die perinataly. To explore the physiological role of Stat5 in the mouse, the corresponding gene locus
targeted with loxP sites was inactivated in β-cells using two lines of Cre recombinase expressing transgenic mice. While the RIP-Cre transgene is
active in pancreatic β-cells and the hypothalamus, the Pdx1-Cre transgene is active in precursor cells of the endocrine and exocrine pancreas.
Mice carrying two floxed Stat5alleles and a RIP-Cre transgene developed mild obesity, were hyperglycemic and exhibited impaired glucose
tolerance. Since RIP-Cre transgenic mice by themselves display some glucose intolerance, the significance of these data is unclear. In contrast,
mice, in which the Stat5 locus had been deleted with the Pdx1-Cre transgene, developed functional islets and were glucose tolerant. Mild glucose
intolerance occurred with age. We conclude that Stat5 is not essential for islet development but may modulate β-cell function.
© 2007 Elsevier B.V. All rights reserved.Keywords: Stat5; Rip-Cre; Pdx1-Cre; Islets of Langerhans; β-cells; Glucose homeostasis1. Introduction
Growth hormone (GH), prolactin (PRL) and placental
lactogen (PL) are potent growth factors for insulinoma cells in
vitro [1–3]. In addition, these hormones stimulate insulin
production in vitro, partially through the transcriptional
activation of the insulin gene promoter [4]. These effects are
mediated through the GH receptor (GHR) and the PRL receptor
(PRLR), which activate the tyrosine kinase Jak2 and the
transcription factors Stat5a and Stat5b (referred to as Stat5)
[5,6]. The mechanisms by which GH and PRL promote β-cell
proliferation and gene expression, and the role of Stat5 haveAbbreviations: Stat, Signal transducer and activator of transcription; JAK,
Janus kinase; GH, growth hormone; PRL, prolactin; PL, placental lactogen;
GHR, GH receptor; PRLR, PRL receptor; FFA, free fatty acid
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doi:10.1016/j.bbamcr.2007.05.010been explored in vitro [7–9]. In insulin-producing INS-1 cells
and in cultured rat islets, GH and PRL induced the phos-
phorylation of Stat5a and Stat5b and their nuclear translocation
[10,11], suggesting their involvement in β-cell physiology. In
support of this, PRLR−/− and GHR−/− mice exhibited a re-
duction in islet density and β-cell mass [12,13]. Pancreatic
insulin mRNA levels were also reduced in adult PRLR-null
mice. In addition, PRLR−/− and GHR−/− mice exhibited
impaired glucose tolerance and increased insulin sensitivity,
respectively. These observations established a physiological
role for GH and PRL in β-cell function and glucose
homeostasis.
Although Stat5 mediates GH- and PRL-induced proliferation
of insulinoma cell lines and insulin gene transcription, and
expression of dominant-negative Stat5 in transgenic mice
resulted in increased body weight and impaired glucose
tolerance [14], the physiological consequences of a complete
absence of Stat5 in β-cells remained elusive. Since Stat5−/−
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of Stat5 in the physiology of β-cells. To address the significance
of Stat5 we deleted the Stat5 locus in the entire pancreas and in
β-cells of mice using Cre-mediated recombination.
2. Results
2.1. Deletion of the Stat5 locus in pancreatic β-cells and the
hypothalamus altered islet morphology and content
Since the complete loss of Stat5 from the mouse genome
results in perinatal lethality [15], we elected to delete Stat5
specifically in the pancreas of the mouse using Cre-mediated
recombination. Two lines of Cre expressing mice were used to
delete the Stat5 locus bracketed by loxP sites. While the RIP-Fig. 1. Targeted disruption of the Stat5 genes and assessment of Stat5 deletion in β
Stat5fl/f l;RIP-Cre mice. (B) Fluorescence immunohistochemical analysis of Stat5 (red
panel) mice. Pancreata from 7-month-old mice were used for immunohistochemical
(C) Impaired glucose homeostasis in 4- to 5-month-old Stat5fl/fl;RIP-Cre mice and RIP-
of 6–8 males of each group. (D) Insulin release from isolated islets. Islets were isolat
5 months. Insulin secretion was induced by basal (3 mM) and 16.7 mM of glucose.Cre transgene [16] is active in pancreatic β-cells and in the
hypothalamus [17], the Pdx1-Cre transgene [18] expresses Cre
in pancreatic precursor cells, which results in the deletion of
floxed genes in exocrine and endocrine cells. Mice were
generated that carried two floxed Stat5 alleles and the RIP-Cre
transgene (Stat5fl/fl; RIP-Cre mice) (Fig. 1A). Stat5b was detected
in β-cells throughout the islets of control mice but not in
Stat5fl/fl; RIP-Cre mice (Fig. 1B). There was no difference in
insulin staining between control and Stat5fl/fl; RIP-Cre mice and
levels of insulin mRNA in islets of these mice were comparable
(data not shown). Loss of Stat5 resulted in a disrupted
architecture of islets as evidenced by the migration of
glucagon-expressing α-cells into the central region of the islets
(Fig. 1B, right panel). Deletion of the Stat5 locus was also
observed in mice older than 1 year (data not shown),-cells of Stat5fl/fl;RIP-Cre mice. (A) Schematic of the construct used to generate
) and glucagon (green) in control (Stat5fl/fl; left panel) and Stat5fl/fl;Rip-Cre (right
analyses. Residual Stat5b-positive cells in Stat5fl/fl;RIP-Cre mice are non-β-cells.
Cre transgenic mice. Results are expressed as average blood glucose level±SEM
ed from two animals per genotype which were used for glucose tolerance test at
(∗, #)Pb0.05; (∗∗, ##)Pb0.01.
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carrying a non-recombined Stat5 locus.
2.2. Stat5fl /f l; RIP-Cre mice developed mild obesity
Up to 12 weeks of age there was no significant difference in
body weight between Stat5fl/fl; RIP-Cre and control mice.
However, older Stat5fl/f l; RIP-Cre mice developed mild obesity
(Table 1) and by 9 months of age, mutant mice weighed on the
average 20% more than their control litter mates. Since the RIP-
Cre transgene is also active in the hypothalamus [17,19], the
developing obesity could be due to the hypothalamic loss of
Stat5 and an altered metabolism. Late-onset obesity was not
observed in RIP-Cre transgenic mice or in Stat5f l/f l; Pdx1-Cre
mice, further implicating hypothalamic Stat5 in the regulation
of metabolism. To explore the overall metabolic consequence in
Stat5fl/f l; RIP-Cre mice, metabolic responses were measured. At
7 months of age, serum glucose levels were slightly elevated
and serum free fatty acids (FFA) and leptin levels were
significantly higher in mutant mice but serum insulin levels
were normal (Table 1). Body composition was measured by
NMR. While the lean mass was similar between mutant and
control mice the adipose tissue mass of Stat5fl/f l; RIP-Cre female
mice was significantly elevated (Table 1).
2.3. Stat5fl/f l; RIP-Cre mice failed to maintain glucose
homeostasis
To examine the impact of the loss of Stat5 on the response to
an acute glucose challenge, glucose disposal was assessed in
fasted mice by glucose tolerance tests. At all ages examined
(6 weeks to 11 months), Stat5f l/f l; RIP-Cre mice displayed higher
glucose levels than the controls at all time points after glucose
injection (Fig. 1C). The severity of impaired glucose response
was increasing in both female and male mice as they aged. As
we described recently [20], RIP-Cre transgenic mice in a
C57BL/6 background display some glucose intolerance as early
as 6 weeks of age. Although glucose intolerance of 4- to 5-
month-old Stat5fl/f l; RIP-Cre mice was more severe than that seenTable 1
Body composition and metabolic parameters of Stat5f l/f l; RIP-Cre mice
Stat5f l/f l Stat5f l/f l; RIP-Cre
Body weight (g) 31.1±0.9 36.8±2.0
Lean mass (g) 22.51±0.6 22.58±0.6
Total adipose mass (g) 5.34±0.9 12.14±1.9 a
Total adipose mass (% body weight) 17.18±2.7 32.11±3.5a
Serum glucose (mg/dl) 189.1±2.8 210.2±8.9 b
Serum insulin (ng/ml) 1.2±0.9 1.2±0.2
Serum TG (mg/dl) 131.6±22.6 156.0±18.9
Serum FFA (mM) 0.4±0.04 0.6±0.05b
Leptin (ng/ml) 10±1.9 21.2±4.2
Weight and body composition was measured in 7-month-old female mice. Blood
was collected from the tail vein directly into non-EDTA-coated capillary tubes
and centrifuged to separate the serum, which was used to assay triglycerides,
FFAs, glucose, insulin and leptin. Values shown are the mean±SEM; seven to
nine mice were used for analysis.
a Pb0.01 vs. Control (Stat5f l/f l).
b Pb0.05 vs. Control (Stat5f l/f l).in RIP-Cre mice (Fig. 1C), both showed reduced insulin
secretion from isolated islets upon challenge with 16.7 mM of
glucose (Fig. 1D).
2.4. Stat5fl/f l; Pdx1-Cre mice exhibit normal glucose homeostasis
Since the presence of the RIP-Cre transgene by itself causes
some glucose intolerance [20,21], we were unable to draw firm
conclusions about the contribution of pancreatic Stat5 in glucose
homeostasis. To bypass this problem, Stat5fl/f l; Pdx1-Cre mice, in
which Cre activity is confined to the pancreas, were generated
(Fig. 2A). Stat5f l/f l; Pdx1-Cremice were observed over a 15-month
period and their weights were indistinguishable from controls
(Table 2). Moreover, levels of glucose, insulin and glucagons
were normal over the 15-month period (Table 2). Islet
architecture and the presence of Stat5b in pancreatic β-cells
were evaluated by immunohistochemical analysis. In control
mice Stat5b was detected throughout the islets (Fig. 2B), but it
was largely absent in Stat5fl/f l; Pdx1-Cre mice (Fig. 2C). The few
remaining Stat5b-positive cells in Stat5fl/f l; Pdx1-Cre mice either
expressed glucagon (Fig. 2C) or somatostatin (data not shown).
This suggests that the Stat5 locus failed to be deleted in a small
number of progenitor cells. In mutant mice, α-cells had migrated
into the central region of the islets (Fig. 2C), but not in control
mice (Fig. 2B). Real-time PCR analysis confirmed the loss of
Stat5b mRNA in islets from Stat5fl/f l; Pdx1-Cre mice compared to
Stat5fl/f l controls. There was no apparent difference in insulin
staining between control and Stat5fl/f l; Pdx1-Cremice (Fig. 2D and
E). Real time PCR confirmed the presence of comparable levels
of insulin mRNA in islets from control and mutant mice, with
beta actin as internal control (data not shown).
To investigate the consequences of the loss of Stat5 on the
response to an acute glucose challenge, glucose disposal was
assessed in fasted mice by glucose tolerance tests. Glucose
levels in fasting Stat5fl/f l; Pdx1-Cre mice prior to the administra-
tion (ip) of glucose were normal in all age groups tested
(Fig. 3A and B). Glucose tolerance was overtly normal in
2–3 months old Stat5fl/f l; Pdx1-Cre mice (Fig. 3A) but mild glucose
intolerance developed in mice older than 6 months (Fig. 3B).
Mouse studies have suggested a role for GH and PRL on β-
cell function during pregnancy. To test whether this effect is
mediated by Stat5, glucose tolerance tests were performed prior
to pregnancy and on day 17 of pregnancy. Stat5fl/f l; Pdx1-Cre
female mice were slightly more glucose intolerant during
pregnancy than their control litter mates (Fig. 3D), but the
differences were not statistically significant. These results imply
that Stat5 signaling contributes to the optimal function of β-
cells under conditions of stress, such as pregnancy and aging.
3. Discussion
Given the established role of GH, PRL and PL in inducing
the proliferation of insulinoma cell lines and insulin gene
transcription and secretion [7,9–11,22], as well as the
involvement of Stat5 in these signaling pathways, more
profound defects in Stat5 mutant mice had been anticipated.
However, studies demonstrating a role for Stat5 in the
Fig. 2. Targeted disruption of the Stat5 genes and assessment of Stat5 deletion in β-cells of Stat5fl/fl; Pdx1-Cre mice. (A) Schematic of the Stat5 locus targeted with loxP
sites and deletion of the Stat5 genes using the Pdx1-Cre transgene. (B, C) Assessment of Stat5 protein levels. Pancreata from 3-month-old mice were used for
immunohistochemical analyses. Sections were stained with antibodies against glucagon (green) and Stat5b (red). Immunofluorescence was viewed under an Olympus
BX51 microscope (Olympus America Inc., Melville, NY) and images were captured with a Nikon DXM1200 digital camera (Nikon Inc., Melville, NY). (D, E)
Fluorescence immunohistochemical analysis of insulin (green) and glucagon (red) in control (d: Stat5fl/fl) and Stat5fl/fl; Pdx1-Cre mice (E).
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in vivo situation since immortalized cell lines are subject to
altered growth control. This study now demonstrates that a
complete absence of Stat5 from pancreatic β-cells in mice has
no discernable impact on islet development and function in
young animals. However, Stat5 appears to be a modulating
component in β-cell function in older mice.Table 2
Stat5 fl/fl Stat5 fl/fl;Pdx1-Cre P-value
Body weight (g) 28.8±1.3 28.7±2.5 0.49
Glucose (mg/dl) 129.5±11.5 139.7±7.9 0.23
Insulin (ng/ml) 0.6±0.3 0.6±0.2 0.22
Glucagon (ng/ml) 246.7±27.5 272.3±89.4 0.61
Blood was collected from the tail vein directly into non-EDTA-coated capillary
tubes and centrifuged to separate the serum, which was used for assay. Values
shown are the mean±SEM; four to five 10- to 15-month-old fed mice were used
for analysis.The obesity, glucose intolerance and metabolic defects
observed upon deletion of the Stat5 locus using the RIP-Cre
transgene are likely not only due to the loss of Stat5 from
pancreatic β-cells, but also the results of other events. In
particular, RIP-Cre mice by themselves develop some glucose
intolerance [21], and loss of Stat5 from the hypothalamus
possibly influences metabolic pathways. Thus these mice are
not suited to explore the role of Stat5 in the physiology of
pancreatic β-cells.
Tissue culture studies have suggested that Stat5 is central to
the GH- and PRL-mediated proliferation of β-cells and the
activation of the genes encoding insulin and cyclin D2 [7–9]. In
support of a role for Stat5, expression of constitutively active
Stat5b in cell lines stimulated GH-independent proliferation
[7,23]. Since functional islets were present in Stat5 mutant mice
analyzed in this study, it is clear that the presence of Stat5 is not
essential for the generation and proliferation of β-cells.
However, no stereological analyses were performed and it is
possible that the β-cell mass in Stat5-mutant mice is slightly
Fig. 3. Results from glucose tolerance tests in Stat5fl/f and Stat5fl/fl; Pdx1-Cre mice. Glucose tolerance tests were performed on fasted mice after an i.p. injection of 2 g/kg
BW glucose at 10 weeks (A) and 6 months (B) of age. Blood glucose values were measured immediately before and 15, 30, 60, and 120 min after glucose injection.
Results are expressed as average blood glucose level±SEM of 6–8 males of each group. (∗) and (∗∗) means Pb0.05 and Pb0.01, respectively, from
independent t-tests (unpaired and two-tailed).P-value fromANOVA (analysis of variance between groups, two-way repeated) was 0.8661 at 10weeks (B) and 0.0007 at
6months (B) of age. (C,D) Glucose tolerance test was performed on 2- to 3-month-old females before pregnancy (C) and on day 17 of gestation (D).Micewere fasted 9 h
and administrated 2 g/kg BW glucose loads at time zero. All results are reported as mean±SEM of 5 females of each group. (∗) means Pb0.05 from t-tests, but ANOVA
shows no significant difference both before pregnancy (P=0.7127) and on day 17 of gestation (P=0.2021).
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reduction in islet density and β-cell mass [12,13] it is possible
that β-cell proliferation is controlled by signaling pathways
other than Stat5. GH and PRL stimulate insulin production in
vitro, in part through the activation of Stat5 and thus a
transcriptional induction of the insulin gene promoter [4–
6,10,11]. Again, we found that levels of insulin mRNA were
unaltered in mutant mice, further demonstrating a negligible
role of Stat5 in the context of the pancreas in vivo.
A recent study also addressed the role of Stat5 in vivo
through the expression in transgenic mice of a dominant-
negative mutant of Stat5b (DNSTAT5) or a constitutively active
mutant of Stat5b (CASTAT5) under control of the rat insulin 1
promoter (RIP) [14]. Mild glucose tolerance, increased body
weight, increased insulin and leptin levels and an increased β-
cell area were observed in DNSTAT5 transgenic mice only on a
high-fat diet but not on a standard diet. Thus, the loss of Stat5 in
islets due to the deletion of the genes or due to expression of a
dominant negative form results in similarly mild defects and
supports the notion that Stat5 modulates β-cell function only
under defined physiological conditions.
Although a wide range of tissue culture cell experiments
have linked Stat5 to many aspects of cell physiology, the
analysis of mice from which Stat5 has been deleted in defined
tissues and cells has not confirmed all of these proposed roles.
Two explanations can be offered for this discrepancy. It ispossible that the functions of Stat5 observed in tissue culture
cells are unique to those experimental systems but do not reflect
the situation encountered in the context of an animal.
Alternatively, it is possible that other members of the Stat
family, namely Stat1 and Stat3, compensate for the loss of Stat5.
Since the Stat3 gene is juxtaposed to the Stat5a/b locus it is
impossible at this time to test this possibility through the
deletion of all three genes.
4. Methods
4.1. Generation of Stat5 fl/fl; RIP-Creand Stat5 fl/fl; Pdx1-Cre mice
Stat5fl/fl mice [15] were bred with RIP-Cre [16] or Pdx1-Cre
[18] transgenic mice. Mice were maintained on a 12-h light, 12-
h dark cycle and fed water and standard diets. The NIDDK
Animal Care and Use Committee approved all procedures and
studies were conducted in accordance with National Institutes
of Health guidelines. Genotyping was performed by PCR
amplification of tail DNA from each mouse at 3 weeks of
age. The primers for genotyping of the Stat5 floxed allele were
primer 1 (5′-GAAAGCATGAAAGGGTTGGAG-3′), primer
2 (5′-AGCAGCAACCAGAGGACTAC-3′) and primer 3 (5′-
AAGTTATCTCGAGTTAGTCAGG-3′). Primer pair 1 and 2
amplifies a fragment of 450 bp from wild-type mice and a 200-
bp fragment was detected by primers 2 and 3; the latter is located
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for the Stat5 floxed allele. Primers for the RIP-Cre transgene
were 5′-CTC TGG CCATCT GCT GAT CC-3′, which binds in
the insulin 2 gene promoter and 5′-CGC CGC ATA ACC AGT
GAA AC-3′, which binds in the Cre sequence. This pair
amplifies a 550 bp Rip–Cre specific fragment. For the detection
of the Pdx1-Cre transgene, 5′-TTGAAACAAGTGCAGGTG
TTC G-3′ and 5′-CCATGA GTG AACGAA CCT GGT CG-3′
were used.
4.2. Preparation of pancreatic sections and
immunohistochemical analyses
Pancreas samples were dissected from fed mice and fixed
with 4% paraformaldehyde/PBS solution overnight at 4 °C.
Five-micrometer longitudinal sections of paraffin-embedded
sections were rehydrated with xylene followed by decreasing
concentrations of ethanol. Antigen retrieval was performed by
heat treatment with an antigen unmasking solution (Vector
Laboratories Inc.), and tissue sections were blocked for 30 min
in PBS-Tween (PBST) containing 3% goat serum. Sections
were incubated with anti-Glucagon (Sigma) and anti-Stat5b (sc-
836, Santa Cruz, Calif.) antibodies. The primary antibodies
were allowed to bind overnight at 4 °C. Secondary antibodies
were from Molecular Probes, Inc. (Eugene, OR) and included
goat anti-rabbit immunoglobulin G (IgG) conjugated to Alexa
Fluor 594 and goat anti-mouse IgG conjugated to Alexa Fluor
488. Sections were incubated in the dark for 30 min, washed
twice in PBST, and mounted with Vectashield (Vector
Laboratories Inc.). Immunofluorescence was viewed under an
Olympus BX51 microscope (Olympus America Inc., Melville,
NY) and images were captured with a Nikon DXM1200 digital
camera (Nikon Inc., Melville, NY).
4.3. Analytical assays and metabolic rates
Blood glucose levels were determined from the tail vein using
a glucometer (Accu-Chek, Roche, Indianapolis, IN). Serum
insulin and leptin levels were measured by radioimmunoassay
(Linco Research Inc., St. Charles, MO). Serum fatty acids and
triglyceride levels were analyzed in fed mice using a commercial
FA kit (Roche, Indianapolis, IN) and the GPO-Trinder kit (Sigma
Chemical Co., St. Louis, MO), respectively. Insulin and glucose
tolerance tests were performed in fasted animals after i.p.
injections of either insulin (0.75 U/kg body weight) or glucose
(2 g/kg body weight). Blood glucose values were measured
immediately before and 15, 30 and 60 min after insulin injection,
and before and 15, 30, 60, and 120 min after glucose injection.
For insulin release, glucose (3 g/kg body weight) or L-arginine
(1 mg/g BW in PBS) [24] was injected IP, and venous blood was
collected at 0, 2.5, 5, 15, and 30 min in chilled heparinized tubes,
immediately centrifuged, and the plasma stored at −20 °C.
Insulin levels were measured with a RIA kit. Metabolic rates
were measured in fed female mice 7 months of age by indirect
calorimetry using the Oxymax system (Columbus Instruments,
Columbus, OH) as described by Héron-Milhavet et al. [25]. Data
were collected for 24 h at room temperature (22 °C) and for 24 hat thermoneutral temperature (30 °C). Data are expressed as the
average of 24 h and normalized to (total body weight)0.75.
4.4. Body composition
Body composition was measured in awake mice using an
NMR analyzer (Bruker Minispec mq10, Bruker Optics Inc.,
Billerica, MA).
4.5. Insulin secretion from isolated islets
Islets were isolated from 4-month-old control (Stat5fl/f) and
Stat5fl/f;RIP-Cre mice by collagenase digestion (Liberase, Roche
Diagnostics, IN) followed by centrifugation over a Histopaque
gradient (Sigma, St. Louis, MO). Islets were handpicked under
a stereo microscope and incubated overnight in RPMI 1640
medium supplemented with 10% FBS, 2 mM L-glutamine,
100 IU/ml penicillin, and 100 μg/ml streptomycin at 37 °C and
5% CO2. For assay of insulin secretion, islets were handpicked
and incubated in Krebs–Ringer solution (119 mM NaCl, 5 mM
KCl, 2.2 mM CaCl2, 1.19 mM KH2PO4, 240 mM NaHCO3,
1.19 mMMgSO4, 10 mM HEPES [pH 7.4], 0.1% bovine serum
albumin, and 3.3 mM glucose) at 37 °C for 45 min. At the end
of the incubation period, islets were transferred to a new 12-well
plate and stimulated with various glucose concentrations
(3.3 mM and 16.7 mM) for 1 h at 37 °C. Supernatants were
collected and insulin release was measured with a rat insulin
ELISA kit (Crystal Chem. Inc., Chicago, IL). Samples were run
in triplicate, and the number of experiments was n=4–5. Total
islet insulin content was measured in batches of five islets. The
islets were sonicated twice in 200 μl acidic ethanol (0.25 mol/l
HCl in 87.5% ethanol) and incubated overnight at 4 °C. The
samples were centrifuged and total insulin was measured in the
supernatant.
4.6. Statistical analysis
All results are reported as mean±SEM for equivalent groups.
Results were compared with independent t-tests (unpaired and
two-tailed) reported as P-values.
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